CD109’s known ability to regulate TGF-β signaling may influence the dynamic balance between TGF-β’s tumor-suppressive and pro-tumorigenic effects, particularly in the inflammatory tumor microenvironment. This evidence concerns the gene TGFB1 and neoplasm.